BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement

Apr.16
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT Chair Luc Jobin told shareholders at the company’s 2026 Annual General Meeting that BAT delivered on its plans in 2025 despite a challenging external environment, with the U.S. business returning to growth, smokeless consumers increasing by more than 15%, improved New Categories contribution, and GBP 6.3 billion returned to shareholders.

Key Takeaways

  • BAT Chair Luc Jobin said at the 2026 AGM that the company delivered at the top end of guidance in 2025 and returned the U.S. business to growth.
  • BAT said the number of consumers choosing its smokeless products increased by more than 15.00% year on year, bringing it closer to its 2030 target of 50 million consumers.
  • The company said it returned GBP 6.30 billion to shareholders in 2025 through dividends and share buy-backs, and about GBP 34.00 billion since 2020.
  • BAT reaffirmed its mid-term algorithm of 3.00% to 5.00% revenue growth, 4.00% to 6.00% adjusted profit from operations growth, and 5.00% to 8.00% adjusted diluted EPS growth.

 2Firsts, April 16, 2026

 

According to BAT’s 2026 Annual General Meeting Chair’s address, Chair Luc Jobin said the company delivered on its commitments in 2025 despite a challenging external environment and is continuing to advance its transformation toward a smokeless business.

 

BAT said it delivered on its 2025 objectives

 

Luc Jobin said 2025 was a year of sharper execution and that BAT delivered at the top end of its guidance. He said the U.S. business returned to growth, combustibles maintained momentum, and Velo Plus delivered strong results. BAT also said the number of consumers choosing its smokeless products increased by more than 15.00% year on year, bringing the company closer to its target of 50 million consumers by 2030. 

 

It added that its New Categories business delivered a significant improvement in category contribution and that GBP 6.30 billion was returned to shareholders through dividends and share buy-backs, taking total shareholder returns since 2020 to about GBP 34.00 billion.

 

The company is advancing its three-year Fit2Win programme

 

Jobin said BAT is implementing Fit2Win, a three-year transformation programme designed to make the business fitter for an increasingly dynamic and digital consumer landscape. According to the address, the programme is intended to make BAT sharper, faster, more data-led, and better equipped for the future.

 

BAT outlined six capabilities underpinning its transformation: advanced consumer insights and foresights, science and stewardship, its R&D ecosystem, its international distribution network, regulatory engagement and tobacco harm reduction, and its digital and AI capabilities.

 

The Chair stressed a smokeless vision and harm-reduction pathway

 

BAT said its vision to Build a Smokeless World is clear and is linked to its ambition to reduce the health impact of its business. Jobin said the company believes that collaboration with policymakers, regulators, and public health authorities is necessary to create the right frameworks to encourage adult smokers who would otherwise continue smoking to switch to lower-risk alternatives.

 

In the address, BAT cited Sweden, the UK, and the U.S. as examples of markets where harm-reduction approaches have shown progress, while pointing to Australia and Brazil as cases where restrictive regulation has coincided with illicit trade growth and rising smoking rates.

 

BAT said 2026 performance is expected at the lower end of the range

 

Looking ahead, Jobin said BAT enters 2026 with accelerating momentum and remains confident in delivering its mid-term algorithm of 3.00% to 5.00% revenue growth, 4.00% to 6.00% adjusted profit from operations growth, and 5.00% to 8.00% adjusted diluted EPS growth.

 

At the same time, the company said it expects 2026 performance to be at the lower end of those ranges, reflecting the time needed to stabilize the APMEA region and continue investing behind premium innovation roll-outs. 

 

BAT also said profit delivery is expected to remain second-half weighted due to the phasing of New Category investment and the build-up of Fit2Win savings during the year.

 

The company added that, at current rates, translational foreign exchange is expected to create a 2.00% to 3.00% headwind on adjusted diluted EPS for both the half year and the full year.

 

BAT said it will continue balancing cash returns and deleveraging

 

BAT said it expects to generate more than GBP 50.00 billion in free cash flow between 2024 and 2030 and will continue to take a disciplined approach to capital allocation. 

 

The company said this includes continued investment in transformation, balancing deleveraging with progressive dividends and sustainable share buy-backs, and pursuing selective bolt-on M&A to accelerate transformation.

 

The company added that it has announced a 2.00% dividend increase and a GBP 1.30 billion share buy-back for 2026, and expects to end the year within its target leverage range of 2.0x to 2.5x.

 

BAT also outlined board and management changes

 

Jobin also referred to board and management changes. BAT said Dragos Constantinescu will join as Chief Financial Officer and Executive Director from September 1, 2026. 

 

Javed Iqbal will continue as Interim Chief Financial Officer until then and will later return to his role as Director, Digital and Information.

 

The Chair said he remains confident in BAT’s transformation

 

In closing, Jobin said BAT has the full set of strengths needed to realize its ambitions and Build a Smokeless World. 

 

He said the company has been shaped for nearly 125 years by shareholder trust and employee commitment, and added that BAT’s transformation to date would be considered extraordinary were it not for the stigma surrounding the industry.

Image source: BAT

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
A proposal by New York Governor Kathy Hochul to impose a steep tax on nicotine pouches has drawn opposition from law-enforcement officials and business groups, who say it could expand the state’s illicit tobacco market. The measure was included in Hochul’s preliminary two-year USD 260 billion budget plan and would treat nicotine pouches like other tobacco products.
Mar.17 by 2FIRSTS.ai
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G reports a 27.6% increase in Q1 operating profit, with traditional and new tobacco sectors driving growth.
May.07 by 2FIRSTS.ai
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada’s federal health minister, Majorie Michel, said she is looking into legislation that would permanently ban the sale of tobacco products to anyone born after 2008. She said Canada has seen the approach recently proposed in the United Kingdom and is reviewing it with partners. Health Canada previously said the Government of Canada has invested C$66 million annually since 2018 to help Canadians quit smoking and reduce the harms of nicotine addiction.
Apr.29 by 2FIRSTS.ai
Korean Vape Retailers Warn of Possible Store Closures After New Tobacco Rules Take Effect
Korean Vape Retailers Warn of Possible Store Closures After New Tobacco Rules Take Effect
South Korea’s revised Tobacco Business Act will take effect on April 24, bringing synthetic nicotine liquid vapes into the legal definition of tobacco and subjecting both retailers and manufacturers to formal regulation.
Apr.13 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai